
CYCC Valuation
Cyclacel Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
CYCC Relative Valuation
CYCC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CYCC is overvalued; if below, it's undervalued.
Historical Valuation
Cyclacel Pharmaceuticals Inc (CYCC) is now in the Fair zone, suggesting that its current forward PS ratio of 207.02 is considered Fairly compared with the five-year average of -1.04. The fair price of Cyclacel Pharmaceuticals Inc (CYCC) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:10.98
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.29
P/B
Median3y
8.49
Median5y
5.46
-51.95
FCF Yield
Median3y
-318.94
Median5y
-210.06
Competitors Valuation Multiple
The average P/S ratio for CYCC's competitors is 40.22, providing a benchmark for relative valuation. Cyclacel Pharmaceuticals Inc Corp (CYCC) exhibits a P/S ratio of 207.02, which is 414.72% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

AVGR
Avinger Inc
0.510
USD
-26.16%

SXTP
60 Degrees Pharmaceuticals Inc
1.330
USD
0.00%

ADTX
Aditxt Inc
1.240
USD
0.00%

SCPX
Scorpius Holdings Inc
0.068
USD
-94.12%

FRGT
Freight Technologies Inc
1.870
USD
0.00%

ACON
Aclarion Inc
7.440
USD
0.00%

NAOV
Nanovibronix Inc
0.925
USD
0.00%

APVO
Aptevo Therapeutics Inc
3.230
USD
+3.19%

BJDX
Bluejay Diagnostics Inc
1.560
USD
0.00%

VLCN
Volcon Inc
15.000
USD
-5.06%
FAQ

Is Cyclacel Pharmaceuticals Inc (CYCC) currently overvalued or undervalued?
Cyclacel Pharmaceuticals Inc (CYCC) is now in the Fair zone, suggesting that its current forward PS ratio of 207.02 is considered Fairly compared with the five-year average of -1.04. The fair price of Cyclacel Pharmaceuticals Inc (CYCC) is between to according to relative valuation methord.

What is Cyclacel Pharmaceuticals Inc (CYCC) fair value?

How does CYCC's valuation metrics compare to the industry average?

What is the current P/B ratio for Cyclacel Pharmaceuticals Inc (CYCC) as of Jul 23 2025?

What is the current FCF Yield for Cyclacel Pharmaceuticals Inc (CYCC) as of Jul 23 2025?

What is the current Forward P/E ratio for Cyclacel Pharmaceuticals Inc (CYCC) as of Jul 23 2025?
